2 false false false false false false false false false false true false false false false false false No description of principal activity 2023-01-13 Sage Accounts Production Advanced 2023 - FRS102_2023 1,670 1,670 217 217 1,453 xbrli:pure xbrli:shares iso4217:GBP 14591467 2023-01-13 2024-01-31 14591467 2024-01-31 14591467 2023-01-12 14591467 bus:Director1 2023-01-13 2024-01-31 14591467 bus:Director2 2023-01-13 2024-01-31 14591467 core:WithinOneYear 2024-01-31 14591467 core:ShareCapital 2024-01-31 14591467 core:RetainedEarningsAccumulatedLosses 2024-01-31 14591467 bus:SmallEntities 2023-01-13 2024-01-31 14591467 bus:AuditExemptWithAccountantsReport 2023-01-13 2024-01-31 14591467 bus:SmallCompaniesRegimeForAccounts 2023-01-13 2024-01-31 14591467 bus:PrivateLimitedCompanyLtd 2023-01-13 2024-01-31 14591467 bus:FullAccounts 2023-01-13 2024-01-31 14591467 core:OfficeEquipment 2023-01-13 2024-01-31 14591467 core:OfficeEquipment 2024-01-31 14591467 bus:Director1 1 2023-01-13 2024-01-31
COMPANY REGISTRATION NUMBER: 14591467
Centaur Bio Limited
Filleted Unaudited Financial Statements
31 January 2024
Centaur Bio Limited
Financial Statements
Period from 13 January 2023 to 31 January 2024
Contents
Page
Statement of financial position
1
Notes to the financial statements
3
Centaur Bio Limited
Statement of Financial Position
31 January 2024
31 Jan 24
Note
£
Fixed assets
Tangible assets
5
1,453
Current assets
Debtors
6
27,875
Cash at bank and in hand
1,803
--------
29,678
Creditors: amounts falling due within one year
7
26,919
--------
Net current assets
2,759
-------
Total assets less current liabilities
4,212
-------
Net assets
4,212
-------
Capital and reserves
Called up share capital
2
Profit and loss account
4,210
-------
Shareholders funds
4,212
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Centaur Bio Limited
Statement of Financial Position (continued)
31 January 2024
These financial statements were approved by the board of directors and authorised for issue on 27 September 2024 , and are signed on behalf of the board by:
Dr M Kab Omir
Mr A J Sheppard
Director
Director
Company registration number: 14591467
Centaur Bio Limited
Notes to the Financial Statements
Period from 13 January 2023 to 31 January 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 71-75 Shelton Street, London, WC2H 9JQ, England.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
25% straight line
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 2 .
5. Tangible assets
Equipment
£
Cost
At 13 January 2023
Additions
1,670
-------
At 31 January 2024
1,670
-------
Depreciation
At 13 January 2023
Charge for the period
217
-------
At 31 January 2024
217
-------
Carrying amount
At 31 January 2024
1,453
-------
6. Debtors
31 Jan 24
£
Other debtors
27,875
--------
7. Creditors: amounts falling due within one year
31 Jan 24
£
Trade creditors
127
Corporation tax
23,792
Other creditors
3,000
--------
26,919
--------
8. Directors' advances, credits and guarantees
During the period a director made advances of £60,000 and made repayments of £46,500. Interest of £438 was charged on the balance and the amount outstanding at the period end was £13,938. During the period a director made advances of £60,000 and made repayments of £46,501. Interest of £438 was charged on the balance and the amount outstanding at the period end was £13,937.